What exactly is it?
An FDA-approved drug, a compounded product, an investigational compound, and an online “research” vial are not interchangeable categories.
New here? Start with three questions
You heard a peptide claim. Here’s how to check it.
You do not need a chemistry degree. You need to separate the molecule, the claim, the evidence, the product, and the current regulatory status—because online hype tends to blend them into one confident sentence.
60-second version
Name the exact product. Find the best human evidence. Then check what FDA has—and has not—actually decided.
- 1 · Product, not just molecule
- 2 · Human evidence, not mechanism
- 3 · Current FDA stage
The fast version
Ask these before you believe—or buy—anything
A confident testimonial cannot answer any of these on its own.
What kind of evidence?
A cell experiment, mouse study, uncontrolled case series, and randomized human trial answer different questions.
What is still unknown?
Long-term safety, interactions, product identity, sterility, and the specific use being promoted may each have a different answer.
The five-minute orientation
Five distinctions that clear most of the fog
01 · Name the category
Start with the product, not just the molecule.
The same compound name can appear in very different contexts. FDA-approved drugs have agency-reviewed evidence and labeling for specific uses. Compounded drugs are not FDA-approved; FDA does not review their safety, effectiveness, or quality before marketing. Investigational compounds may be studied in humans without being approved. Products sold online as “research use only” are not made safe or suitable for people by that disclaimer.
Approved drugApproval applies to a particular product and labeled use—not every claim about the molecule.
Compounded drugMay meet an individual medical need, but is not FDA-approved and carries different oversight and quality considerations.
InvestigationalBeing studied does not mean the benefit is established or the product is approved.
Online “research” productA seller’s label or test document cannot substitute for product-specific regulatory review.
02 · Read the evidence ladder
“There’s a study” is the beginning of the question.
Look for the population, comparison group, measured outcome, study size, and whether the promoted use matches what researchers actually tested. PepCurrent labels evidence type because the hierarchy matters.
01Randomized human evidenceBest suited to testing whether an intervention caused a measured outcome in the studied population.
02Other human evidenceCan identify signals, but uncontrolled or observational designs have important limits.
03Animal evidenceUseful for research questions; not proof that the same benefit or risk occurs in people.
04Cell or mechanism evidenceCan explain a pathway without establishing a useful treatment effect in a person.
05AnecdoteMay describe a real experience but cannot isolate cause, product identity, dose accuracy, or expectation effects.
03 · Keep regulatory stages separate
“Discussed,” “recommended,” and “approved” are not synonyms.
An FDA staff review is not an advisory-committee recommendation. An advisory recommendation is not FDA’s final determination. Bulks List consideration is not drug approval. PepCurrent’s FDA Tracker separates each stage and attaches the official source.
04 · Do not let a COA answer the wrong question
A test document is not a safety verdict.
A certificate of analysis may describe a sample and a set of tests. By itself, it does not establish that the document belongs to the product in hand, that every batch matches, that an injectable product is sterile, that the promoted use works, or that the product is appropriate for a particular person. PepCurrent does not rank vendors or treat a COA as a substitute for regulatory oversight.
05 · Bring better questions
Personal medical decisions need someone who knows your history.
Useful questions for a licensed clinician include: What human evidence addresses this exact use? Is the product FDA-approved or compounded? Is there an approved alternative? What is known about interactions with my conditions and medications? What symptoms require urgent care? PepCurrent can organize public evidence; it cannot evaluate your individual risks or tell you to start, stop, or change a treatment.
The trust boundary
What PepCurrent will not turn into content
No buying guides.No vendor rankings, affiliate links, discount codes, or “trusted source” lists.
No protocols.No dosing, cycles, stacks, reconstitution, injection, or sourcing instructions.
No personal clearance.No interaction checker or red/green answer based on your medications or history.
No certainty theater.Unknown, not studied in humans, and not enough evidence are complete answers.
Choose your path
Go straight to the kind of answer you need
Look up a compoundHuman evidence, animal evidence, safety unknowns, and sources.Peptide Library →Check a claimThe internet version, the source version, and the missing context.Claim Check →Check a combination or COADirect combination evidence, product-quality questions, and monitored claims.Research Desk →Follow FDA statusStaff position, committee recommendation, and final determination.FDA Tracker →Audit our workSee source logs, the structured registry, version history, and corrections.Receipts →
Source notes
The official distinctions behind this page
FDA — Understanding the Risks of Compounded Drugs explains that compounded drugs are not FDA-approved and are not reviewed for safety, effectiveness, or quality before marketing. FDA — Compounding and the FDA: Questions and Answers explains when compounding may serve a patient need and why it is not the same as an approved drug. Regulatory-stage language is linked through the PepCurrent FDA Tracker.
If someone may be having a medical problem
Get help first. Report later.
PepCurrent cannot assess symptoms or provide emergency triage.
Call 911 nowIf someone collapses, has a seizure, has trouble breathing, or cannot be awakened.
U.S. Poison ControlCall 1-800-222-1222 or visit Poison.org.
Personal medical questionsContact a licensed clinician who can evaluate the person and their medical history.
Serious product problemAfter appropriate care, patients and clinicians can use FDA MedWatch.
U.S. resources · checked July 16, 2026 · Open the full Help Now page →